ChIP sequencing of cyclin D1 reveals a transcriptional role in chromosomal instability in mice
Open accessAbstract
Chromosomal instability (CIN) in tumors is characterized by chromosomal abnormalities and an altered gene expression signature; however, the mechanism of CIN is poorly understood. CCND1 (which encodes cyclin D1) is overexpressed in human malignancies and has been shown to play a direct role in transcriptional regulation. Here, we used genome-wide ChIP sequencing and found that the DNA-bound form of cyclin D1 occupied the regulatory region of genes governing chromosomal integrity and mitochondrial biogenesis. Adding cyclin D1 back to Ccnd1(-/-) mouse embryonic fibroblasts resulted in CIN gene regulatory region occupancy by the DNA-bound form of cyclin D1 and induction of CIN gene expression. Furthermore, increased chromosomal aberrations, aneuploidy, and centrosome abnormalities were observed in the cyclin D1-rescued cells by spectral karyotyping and immunofluorescence. To assess cyclin D1 effects in vivo, we generated transgenic mice with acute and continuous mammary gland-targeted cyclin D1 expression. These transgenic mice presented with increased tumor prevalence and signature CIN gene profiles. Additionally, interrogation of gene expression from 2,254 human breast tumors revealed that cyclin D1 expression correlated with CIN in luminal B breast cancer. These data suggest that cyclin D1 contributes to CIN and tumorigenesis by directly regulating a transcriptional program that governs chromosomal stability.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Cyclin D1 binds with some preference to sites that also associate with p53.
“Interestingly, one of the genome-wide ChIP analyses revealed that Cyclin D1 binds with some preference to sites that also associate with p53, among other transcription factors43.”
From CDK4 inhibition diminishes p53 activation by MDM2 antagonists (2018) · cites this paper as [43]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 64 · Cited by 115
Research works printed but not linked: 1
- - 2009;28(15):1812-1820.
- Authors
- Casimiro, M. C., Crosariol, M., Loro, E., Ertel, A., Yu, Z., Dampier, W., Saria, E. A., Papanikolaou, A., Stanek, T. J., Li, Z., Wang, C., Fortina, P., Addya, S., Tozeren, A., Knudsen, E. S., Arnold, A., & Pestell, R. G.
- Affiliations
- Thomas Jefferson University (US)
- Drexel University (US)
- University of Connecticut (US)
- Corresponding author
- Pestell, Richard G.
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2012-03-01
- Volume
- 122
- Issue
- 3
- Pages
- 833-843
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC3287228
- OpenAlex
- W2005722441
- Cited by
- 115
- References
- 64
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 1 · 2023: 4 · 2022: 4 · 2021: 9 · 2020: 11 · 2019: 8 · 2018: 10 · 2017: 9 · 2016: 8 · 2015: 13 · 2014: 14 · 2013: 13 · 2012: 5
- FWCI
- 6.78
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- The Medicine Forum (submittedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Funders
- Pennsylvania Department of Health
- China Scholarship Council
- National Institutes of Health
- National Cancer Institute (R01CA13749, R01CA055909, R01 CA12934, R01CA086072, R01CA075503, R01CA070896, P30CA056036)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- cyclin D1, CCND1, chromosomal instability, transcriptional regulation, chromosome stability, aneuploidy, centrosome abnormalities, mitochondrial biogenesis, breast cancer, luminal B, cancer susceptibility, gene regulatory regions
- MeSH terms
- Animals, Binding Sites, Breast Neoplasms, Chromosome Aberrations, Female, Fibroblasts, Humans, Karyotyping, Mice, Transgenic, Transcription, Genetic, Gene Expression Regulation, Neoplastic, Cyclin D1, Chromosomal Instability, Cell Line, Tumor, Chromatin Immunoprecipitation, Mice, Genome-Wide Association Study
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review